Latest Breaking News On - Capital markets investor relations - Page 5 : comparemela.com
Bicycle Therapeutics plc: Bicycle Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Bicycle Therapeutics plc: Bicycle Therapeutics Announces Restrictions on Shareholder Attendance at Annual General Meeting to be Held on June 28, 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Bicycle Therapeutics plc: Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences
Bicycle
) technology, today announced that management will participate in the following virtual investor conferences in June:
Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021; fireside chat at 11:00 a.m. ET
Goldman Sachs 42
nd Annual Global Healthcare Conference on Tuesday, June 8, 2021; fireside chat at 8:00 a.m. ET
The JMP Securities Life Sciences Conference on Thursday, June 17, 2021; fireside chat at 12:00 p.m. ET
A live webcast of the fireside chats will be accessible in the Investors Media section of Bicycle s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the presentation dates.
Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
BT7480, the lead Bicycle
tumor-targeted immune cell agonist, presented at AACR Annual Meeting 2021 New Drugs on the Horizon session; remains on-track for 2H 21 clinical trial start
Achieved significant recent progress across pipeline of Bicycle
-based therapies beyond oncology
Raised $75.0 million through at-the-market offering program; cash of $195.9 million as of March 31, 2021 expected to provide financial runway through multiple clinical milestones and into 2024
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (
Bicycle) technology, today reported financial results for the first quarter ended March 31, 2021 and discussed recent corporate updates.